Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
by Dr V. R.
Badrakalimuthu and Dr D.
Last updated: October 2013
It is estimated that around 216,000
individuals in the UK are chronically infected with
the hepatitis C virus (HCV) (Health
Protection Agency, 2012).
The prevalence of HCV infection among
intravenous drug users varies between 53% and 96%. The
prevalence in the sub-group of a population on methadone
maintenance programme is between 67% and 96% (Novick, 2008).
Psychiatrists need to be aware of the
important and complex issues involved in the treatment of substance
use disorders presenting with co-occurring severe mental illness
and HCV infection.
The aim of this module is to explore the
relationship between hepatitis C and mental health and to offer
guidance on management. This is particularly applicable to
substance misuse and liaison psychiatrists as they deal with the
complex areas of hepatitis C, substance misuse and the effects
on physical and mental health.
If you like this module, you may also be
Dual diagnosis: the diagnosis and treatment of
depression with co-existing substance misuse by Dr Roger Bloor
and Professor Ilana Crome
Essentials of Physical Health in Psychiatry (book from RCPsych
Related Advances articles
Download take-home notes to print and